EMERALD THERAPEUTICS Trademark

Trademark Overview

On Friday, March 9, 2018, a trademark application was filed for EMERALD THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EMERALD THERAPEUTICS trademark a serial number of 87828013. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 15, 2021. This trademark is owned by Emerald Therapeutics, Inc.. The EMERALD THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used to treat viral infections; pharmaceutical preparations, namely, nucleic acids for therapeutic use; pharmaceutical preparations used to detect and regulate target polynucleotides
emerald therapeutics

General Information

Serial Number87828013
Word MarkEMERALD THERAPEUTICS
Filing DateFriday, March 9, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 15, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 14, 2018

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical preparations used to treat viral infections; pharmaceutical preparations, namely, nucleic acids for therapeutic use; pharmaceutical preparations used to detect and regulate target polynucleotides

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 16, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmerald Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameEmerald Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, November 15, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 15, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 5, 2021EXTENSION 5 GRANTED
Thursday, April 8, 2021EXTENSION 5 FILED
Thursday, April 22, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 8, 2021TEAS EXTENSION RECEIVED
Thursday, October 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 6, 2020EXTENSION 4 GRANTED
Tuesday, October 6, 2020EXTENSION 4 FILED
Tuesday, October 6, 2020TEAS EXTENSION RECEIVED
Friday, April 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 1, 2020EXTENSION 3 GRANTED
Wednesday, April 1, 2020EXTENSION 3 FILED
Wednesday, April 1, 2020TEAS EXTENSION RECEIVED
Thursday, September 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 17, 2019EXTENSION 2 GRANTED
Tuesday, September 17, 2019EXTENSION 2 FILED
Tuesday, September 17, 2019TEAS EXTENSION RECEIVED
Tuesday, April 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 5, 2019EXTENSION 1 GRANTED
Friday, April 5, 2019EXTENSION 1 FILED
Friday, April 5, 2019TEAS EXTENSION RECEIVED
Tuesday, October 9, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 14, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 14, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 6, 2018ASSIGNED TO LIE
Thursday, June 21, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 21, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, June 21, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 21, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, June 21, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, June 21, 2018ASSIGNED TO EXAMINER
Friday, March 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 13, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics emerald preparations pharmaceutical used regulate detect polynucleotides therapeutic target namely treat